Millennium Management
RCUS icon

Millennium Management’s Arcus Biosciences RCUS Stock Holding History

Millennium Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-168,876
Closed -$4.02M – 6268
2025
Q4 		$4.02M Sell
168,876
-466,068
-73% -$9.51M ﹤0.01% 3254
2025
Q3 		$8.64M Sell
634,944
-145,144
-19% -$1.51M ﹤0.01% 2539
2025
Q2 		$6.35M Sell
780,088
-414,534
-35% -$3.54M ﹤0.01% 2742
2025
Q1 		$9.38M Buy
1,194,622
+270,253
+29% +$3.13M 0.01% 2257
2024
Q4 		$13.8M Buy
924,369
+679,267
+277% +$11.1M 0.01% 1865
2024
Q3 		$3.75M Buy
245,102
+69,397
+39% +$1.09M ﹤0.01% 3103
2024
Q2 		$2.68M Buy
+175,705
New +$2.84M ﹤0.01% 3277
2024
Q1 		– Sell
-31,394
Closed -$543K – 6559
2023
Q4 		$600K Sell
31,394
-68,784
-69% -$1.1M ﹤0.01% 4530
2023
Q3 		$1.8M Buy
100,178
+44,833
+81% +$901K ﹤0.01% 3659
2023
Q2 		$1.12M Buy
+55,345
New +$1.05M ﹤0.01% 3950
2023
Q1 		– Sell
-144,627
Closed -$2.76M – 6769
2022
Q4 		$2.99M Buy
144,627
+132,066
+1,051% +$3.63M ﹤0.01% 3218
2022
Q3 		$329K Sell
12,561
-111,199
-90% -$2.94M ﹤0.01% 5289
2022
Q2 		$3.14M Buy
123,760
+98,303
+386% +$2.41M ﹤0.01% 3248
2022
Q1 		$803K Sell
25,457
-48,438
-66% -$1.62M ﹤0.01% 4741
2021
Q4 		$2.99M Buy
73,895
+62,151
+529% +$2.41M ﹤0.01% 3388
2021
Q3 		$410K Sell
11,744
-160,988
-93% -$5.01M ﹤0.01% 5527
2021
Q2 		$4.74M Buy
172,732
+144,969
+522% +$4.14M ﹤0.01% 2829
2021
Q1 		$780K Buy
27,763
+10,891
+65% +$379K ﹤0.01% 4440
2020
Q4 		$438K Sell
16,872
-286,157
-94% -$6.93M ﹤0.01% 4300
2020
Q3 		$5.19K Sell
303,029
-166,378
-35% -$3.72M 0.01% 1803
2020
Q2 		$11.6M Buy
469,407
+15,719
+3% +$424K 0.02% 1118
2020
Q1 		$6.3M Buy
453,688
+302,739
+201% +$3.77M 0.01% 1159
2019
Q4 		$1.52M Sell
150,949
-37,550
-20% -$316K ﹤0.01% 2772
2019
Q3 		$1.72M Buy
188,499
+110,763
+142% +$890K ﹤0.01% 2541
2019
Q2 		$618K Buy
+77,736
New +$778K ﹤0.01% 3088
2018
Q4 		– Sell
-141,077
Closed -$1.97M – 4100
2018
Q3 		$1.97M Buy
141,077
+113,654
+414% +$1.45M ﹤0.01% 2451
2018
Q2 		$336K Sell
27,423
-178,518
-87% -$2.8M ﹤0.01% 3335
2018
Q1 		$3.18M Buy
+205,941
New +$3.43M ﹤0.01% 2067

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Millennium Management's RCUS Position: Q1 2026 in Review

Millennium Management sold out of Arcus Biosciences (RCUS) in Q1 2026, closing a stake of 168,876 shares — an estimated $4.02M sold.

Millennium Management first reported a position in RCUS in Q1 2018 and held it in 28 quarters. The position peaked at $13.8M in Q4 2024. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Millennium Management reported no remaining Arcus Biosciences position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 168,876 Arcus Biosciences shares in Q1 2026, an estimated $4.02M.
  • Millennium Management first reported a position in Arcus Biosciences in Q1 2018 and held it in 28 quarters.
  • Millennium Management's Arcus Biosciences position peaked at $13.8M in Q4 2024.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.